BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17207027)

  • 21. Monocyte chemoattractant chemokines in cystic fibrosis.
    Rao S; Wright AK; Montiero W; Ziegler-Heitbrock L; Grigg J
    J Cyst Fibros; 2009 Mar; 8(2):97-103. PubMed ID: 19000946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
    Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
    J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations.
    Newport S; Amin N; Dozor AJ
    Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory response to sputum induction measured by exhaled markers.
    Antczak A; Kharitonov SA; Montuschi P; Gorski P; Barnes PJ
    Respiration; 2005; 72(6):594-9. PubMed ID: 15988171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.
    Wood LG; Garg ML; Simpson JL; Mori TA; Croft KD; Wark PA; Gibson PG
    Am J Respir Crit Care Med; 2005 Mar; 171(5):426-30. PubMed ID: 15579724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.
    Chaudhuri R; McMahon AD; Thomson LJ; MacLeod KJ; McSharry CP; Livingston E; McKay A; Thomson NC
    J Allergy Clin Immunol; 2004 Jun; 113(6):1063-70. PubMed ID: 15208586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
    Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
    Chiron R; Grumbach YY; Quynh NV; Verriere V; Urbach V
    J Cyst Fibros; 2008 Nov; 7(6):463-8. PubMed ID: 18541460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
    Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
    Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma.
    Louhelainen N; Rytilä P; Obase Y; Mäkelä M; Haahtela T; Kinnula VL; Pelkonen A
    J Asthma; 2008 Mar; 45(2):149-54. PubMed ID: 18350407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
    Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
    Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
    Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary profile and oxidative stress in children and adolescents with cystic fibrosis.
    Livnat G; Bentur L; Kuzmisnsky E; Nagler RM
    J Oral Pathol Med; 2010 Jan; 39(1):16-21. PubMed ID: 19656266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between exhaled leukotriene and 8-isoprostane levels and asthma severity, asthma control level, and asthma control test score.
    Keskin O; Balaban S; Keskin M; Kucukosmanoglu E; Gogebakan B; Ozkars MY; Kul S; Bayram H; Coskun Y
    Allergol Immunopathol (Madr); 2014; 42(3):191-7. PubMed ID: 23265270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.